These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 32931661
1. Analysis of chemotherapy effect on the second primary malignancy for head and neck cancer patients by a nomogram based on SEER database. Li X, Guo K, Feng Y, Guo Y. Cancer Med; 2020 Nov; 9(21):8029-8042. PubMed ID: 32931661 [Abstract] [Full Text] [Related]
2. Association between postoperative radiotherapy for young-onset head and neck cancer and long-term risk of second primary malignancy: a population-based study. Zhu X, Zhou J, Zhou L, Zhang M, Gao C, Tao L. J Transl Med; 2022 Sep 05; 20(1):405. PubMed ID: 36064552 [Abstract] [Full Text] [Related]
4. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma. Lee DH, Roh JL, Baek S, Jung JH, Choi SH, Nam SY, Kim SY. Otolaryngol Head Neck Surg; 2013 Oct 05; 149(4):579-86. PubMed ID: 23820107 [Abstract] [Full Text] [Related]
5. Mortality patterns of patients with tonsillar squamous cell carcinoma: a population-based study. Wang J, Li X, Niu D, Huang J, Ye E, Zhao Y, Yue S, Hou X, Wu J. Front Endocrinol (Lausanne); 2023 Oct 05; 14():1158593. PubMed ID: 38130394 [Abstract] [Full Text] [Related]
6. Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database. Birkeland AC, Rosko AJ, Chinn SB, Prince ME, Sun GH, Spector ME. ORL J Otorhinolaryngol Relat Spec; 2016 Oct 05; 78(2):61-9. PubMed ID: 26910465 [Abstract] [Full Text] [Related]
9. Chemotherapy for primary cancer can reduce the risk of head and neck second primary malignancy: a propensity-matched analysis. Xiong L, Yu H, Wei W, Wang C, Li B, Liu H, Cheng A, Li D, Han Z, Feng Z. Clin Oral Investig; 2023 Feb 05; 27(2):571-580. PubMed ID: 36239788 [Abstract] [Full Text] [Related]
15. Development and validation of prognostic nomogram in patients with nonmetastatic malignant melanoma: a SEER population-based study. Xiao Y, Peng S, Hu Y, Zhang J, Cao X. Cancer Med; 2020 Nov 05; 9(22):8562-8570. PubMed ID: 32941704 [Abstract] [Full Text] [Related]
18. Development and validation of nomogram to predict risk of survival in patients with laryngeal squamous cell carcinoma. Cui J, Wang L, Zhong W, Chen Z, Tan X, Yang H, Chen J, Liu G. Biosci Rep; 2020 Aug 28; 40(8):. PubMed ID: 32744320 [Abstract] [Full Text] [Related]